AusperBio Therapeutics Inc. Clinical Trial Pipeline: 3 Active Trials, 2 Changes This Month

3

Active Trials

2

Recruiting

2

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-08-07	NCT07654283 Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe…	Recruitment opened
2026-08-07	NCT07654283 Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe…	date change Primary completion pushed: 2027-03-24 -> 2027-05-11

Active Trials by Phase

Phase 2

2

Phase 1

1

Active Trials

NCT ID	Title	Condition	Status
Phase 2
NCT07370207	Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia…	Hepatitis B, Chronic	Recruiting
NCT07654283	Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe…	Hepatitis B, Chronic	Recruiting
Phase 1
NCT07617194	Study of AHB-171 in Chronic Hepatitis B Participants	Hepatitis B, Chronic	Not Yet Recruiting

Get alerts when AusperBio Therapeutics Inc.'s trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.